HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Mitchell L Shiffman Selected Research

Retreatment

11/2011Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment response.
6/2009Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results.
1/2007Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C.
12/2006Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.
5/2004Retreatment of patients who do not respond to initial therapy for chronic hepatitis C.
1/2004Management of patients with chronic hepatitis C virus infection and previous nonresponse.
11/2002Retreatment of patients with chronic hepatitis C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Mitchell L Shiffman Research Topics

Disease

57Chronic Hepatitis C
10/2014 - 09/2002
49Fibrosis (Cirrhosis)
12/2015 - 01/2003
38Infection
12/2015 - 09/2002
23Hepatitis C
08/2014 - 01/2003
10Hepatitis B
08/2012 - 02/2003
10Anemia
11/2011 - 05/2004
9Liver Diseases (Liver Disease)
02/2014 - 09/2003
7Body Weight (Weight, Body)
05/2014 - 09/2002
7Chronic Hepatitis B
09/2011 - 02/2003
6End Stage Liver Disease
05/2013 - 08/2004
5Inflammation
07/2014 - 01/2004
5Hepatocellular Carcinoma (Hepatoma)
05/2013 - 11/2003
4Disease Progression
11/2009 - 11/2003
3Nausea
09/2008 - 05/2004
3Fatty Liver
08/2007 - 06/2003
2Thrombocytopenia (Thrombopenia)
02/2014 - 11/2007
2Hemolytic Anemia
02/2012 - 10/2010
2Chronic Kidney Failure (Chronic Renal Failure)
09/2011 - 04/2007
2Neutropenia
07/2011 - 08/2008
2Viremia
11/2008 - 10/2004
2Neoplasms (Cancer)
02/2008 - 02/2003
2Pain (Aches)
02/2008 - 12/2007
2Fatigue
02/2008 - 02/2006
2Headache (Headaches)
11/2007 - 05/2004
2Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
08/2007 - 09/2003
1Portal Hypertension
11/2015
1Exanthema (Rash)
11/2011
1Hemolysis
11/2010
1Acute Kidney Injury (Acute Renal Failure)
08/2009
1Delirium
08/2009
1Hemorrhage
03/2009
1Renal Insufficiency (Renal Failure)
03/2009
1Bacterial Infections (Bacterial Infection)
03/2009
1Vomiting
09/2008
1Autoimmune Hepatitis
09/2008
1Anorexia
02/2008
1Arthralgia (Joint Pain)
02/2008
1Cataract (Cataracts)
12/2007

Drug/Important Bio-Agent (IBA)

61Ribavirin (Virazole)FDA LinkGeneric
12/2015 - 09/2002
34InterferonsIBA
08/2015 - 01/2003
20RNA (Ribonucleic Acid)IBA
08/2014 - 01/2003
14peginterferon alfa-2a (Pegasys)FDA Link
04/2014 - 09/2002
9Alanine Transaminase (SGPT)IBA
12/2010 - 01/2003
7Interferon-alpha (Interferon Alfa)FDA Link
10/2014 - 07/2003
6AntigensIBA
01/2011 - 02/2003
5Protease Inhibitors (Protease Inhibitor)IBA
12/2015 - 05/2004
5adefovir dipivoxil (Hepsera)FDA Link
09/2011 - 02/2003
4Hepatitis B e AntigensIBA
01/2011 - 02/2003
3Ritonavir (Norvir)FDA Link
11/2015 - 05/2014
3ribavirin amidine (viramidine)IBA
10/2010 - 04/2007
3Non-alcoholic Fatty Liver DiseaseIBA
02/2007 - 06/2003
3Epoetin Alfa (Epogen)FDA Link
06/2005 - 05/2004
2eltrombopagFDA Link
02/2014 - 11/2007
2hepatitis B hyperimmune globulinIBA
08/2012 - 01/2008
2emtricitabine (Emtriva)FDA Link
08/2012 - 01/2006
2tenofovirFDA Link
08/2012 - 12/2008
2telaprevirIBA
02/2012 - 11/2011
2tenofovir disoproxil (Viread)FDA Link
01/2011 - 12/2008
2AntibodiesIBA
09/2009 - 06/2005
2peginterferon alfa-2b (Pegintron)FDA Link
08/2009 - 06/2005
2DNA (Deoxyribonucleic Acid)IBA
12/2008 - 02/2003
2EnzymesIBA
09/2008 - 06/2004
2ErythropoietinFDA Link
04/2007 - 06/2005
2Interferon Alfa-2b (Interferon Alfa 2b)FDA Link
09/2005 - 09/2002
1Biological Markers (Surrogate Marker)IBA
11/2015
1Antiviral Agents (Antivirals)IBA
05/2014
1Fumigant 93 (D-D)IBA
03/2013
1Lipoproteins (Lipoprotein)IBA
03/2013
1N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
02/2012
1inosine triphosphataseIBA
02/2012
1CreatinineIBA
07/2011
1Glucose (Dextrose)FDA LinkGeneric
07/2011
1Hepatitis B virus P proteinIBA
01/2011
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2010
1HematinicsIBA
11/2010
1InterleukinsIBA
07/2010
1TeaIBA
11/2009
1CoffeeFDA Link
11/2009
1Hepatitis A AntibodiesIBA
09/2009
1twinrixIBA
09/2009
1VaccinesIBA
09/2009
1Hepatitis A Vaccines (Hepatitis A Vaccine)IBA
09/2009
1Prednisone (Sone)FDA LinkGeneric
09/2008
1mycophenolate mofetil (Cellcept)FDA LinkGeneric
09/2008
1Azathioprine (Imuran)FDA LinkGeneric
09/2008
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2008
1R1626IBA
08/2008
1SilymarinIBA
02/2008
1SteroidsIBA
12/2007
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
12/2007
1AnticoagulantsIBA
12/2007
1bromfenacFDA Link
12/2007

Therapy/Procedure

18Liver Transplantation
05/2013 - 06/2003
11Transplants (Transplant)
08/2008 - 02/2003
8Transplantation (Transplant Recipients)
05/2013 - 02/2003
7Retreatment
11/2011 - 11/2002
2Highly Active Antiretroviral Therapy (HAART)
12/2010 - 05/2004
2Homologous Transplantation (Allograft)
03/2009 - 07/2004
2Aftercare (After-Treatment)
11/2008 - 11/2003
1Renal Dialysis (Hemodialysis)
09/2011